1[1]Chan JK, Ng CS, Hui PK et al. Anaplastic large cell Ki-1 Lymphoma, Delineation of two morphological types. Histopathology, 1989,15:11
2[2]Offit K, Ladanyi M, Gangi MD et al. Ki-1 antigen expression defines a favorable clinical subset of non-B cell non-Hodgkin's lymphoma. Leukemia,1990,4:625
3[3]Sherman CG,Zielenska M,Lorenzana AN et al. Morphological and phenotypic features in pediatric large cell lymphoma and their correlation with ALK expression and the t(2; 5) (p23; q35) translocation. Pediatr Dev Pathol, 2001,4:129
4[4]Drexler HG,Gignac SM, von Wasielewski R et al. Pathobiology of NPMALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas. Leukemia, 2000,14:1533
5[5]Madero L, Benito AI, Quintero V et al.Ki-1 + anaplastic large cell lymphoma in a child with unpredictable clinical course. Pediatr Hematol Oncol,2001,18:143
6[6]Mora J, Filippa DA, Thaler HT et al. Large cell non-Hodgkin lymphoma of childhood: analysis of 78 consecutive patients enrolled in 2 consecutive protocols at the Memorial Sloan-Kettering Cancer Center. Cancer, 2000,88:186
7[7]Thomas JO, Beiske K, Hann I et al. Immunohistological diagnosis of "plasmacytoid T cell lymphoma" in paraffin wax sections. J Clin Pathol,1991,44:632
9[9]Muller-hermelink HK, Stein H, Steinmann G et al. Malignant lymphoma of plasmacytoid T-cells: Morphologic and immunologic studies characterizing a special type ofT-cell. Am J Surg Pathol, 1983,7:849
10[10]Gatter KM, Rader A, Braziel RM, Fine-needle aspiration biopsy of anaplastic large cell lymphoma, small cell variant with prominent plasmacytoid features: case report. Diagn Cytopathol, 2002,26:113
6Soutar R, Lucraft H, Jackson G, et al, Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary ex- trameduilary plasmacytoma [J]. Br J Haematol, 2004, 124 (6): 717-726.
7Greipp PR, San Mignal J, Dude BG, et al. International staging sys- tem for multiple myeloma [J]. J Clin Oncol, 2005, 23 (15): 3412-3420.
8George ED, Sadovsky R. Multiple myeloma: recognition and management[J]. American Family Physician, 1999, 59(7): 1885-1894.
9Hiura K, Wilde J, Moriyama K, et al. Role for macrophage inflammatory protein MIP-lalpha and MIP-lbeta in the development of osteolytic lesions in multiple rnyeloma [J]. Blood, 2002, 100 (6): 2195-2202.
